July 1 (Reuters) - Amplia Therapeutics Ltd (ATX) :
- ANNOUNCES UNDERWRITTEN PRO RATA ACCELERATED NON-RENOUNCEABLE ENTITLEMENT OFFER
- FULLY UNDERWRITTEN 3 FOR 5 ACCELERATED, PRO RATA NON- RENOUNCEABLE ENTITLEMENT OFFER AT $0.10 PER SHARE TO RAISE ABOUT $4.0 MILLION
- AMPLIA THERAPEUTICS LTD-PROCEEDS FROM OFFER WILL BE USED TO FUND A PHASE I CLINICAL TRIAL FOR AMP945 AND PRE- CLINICAL STUDIES
News: ATX Amplia Therapeutics Announces Entitlement Offer To Fund Phase 1 Clinical Trial
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.65M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $141.2K | 855.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 567120 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 164558 | 2 |
View Market Depth
| Last trade - 11.32am 15/09/2025 (20 minute delay) ? |
| ATX (ASX) Chart |